Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 8/20 | 0.65 |
| ▸ | NPC1 | O15118 | 4/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.61 |
| ▸ | DRD2 | P14416 | 2/20 | 0.61 |
| ▸ | DRD4 | P21917 | 2/20 | 0.61 |
| ▸ | DRD3 | P35462 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28842593 | 1.00 | GFER (0.71) | GFERRAB9ANPC1GAAPOLB | |
| Hydrochloric Acid SCHEMBL1715319 | 0.98 | GFER (0.69) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL5385321 | 0.85 | GFER (0.71) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL203617 | 0.83 | GFER (1.00) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL201539 | 0.81 | GFER (0.72) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL201736 | 0.81 | GFER (0.72) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL19031390 | 0.81 | GFER (0.72) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL2706140 | 0.81 | GFER (0.72) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL19031364 | 0.81 | GFER (0.72) | GFERRAB9ANPC1GAAPOLB | |
| SCHEMBL5377137 | 0.81 | CYP19A1 (0.61) | GFERRAB9ANPC1GAAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106608873-B | Pyrazol acid amide compounds and the preparation method and application thereof | 湖南化工研究院有限公司 | 2019-05-24 | — | — | CN | claimed |
| CN-109054648-A | Serosity combination for chemically mechanical polishing | LTCAM有限公司 | 2018-12-21 | — | — | CN | claimed |
| CN-106608873-A | Pyrazole amide compound, and preparation method and application thereof | 湖南化工研究院有限公司 | 2017-05-03 | — | — | CN | claimed |
| CN-104419326-A | Slurry composition for chemical mechanical polishing | COWON INNOTECH INC | 2015-03-18 | — | — | CN | claimed |
| US-12319684-B2 | Agonists of the apelin receptor and methods of use thereof | Sanford Burnham Prebys Medical Discovery Institute (US) | 2025-06-03 | — | — | US | disclosed |
| US-20240270737-A1 | SMALL MOLECULAR INHIBITORS OF STING SIGNALING COMPOSITIONS AND METHODS OF USE | STINGINN INC. (US) | 2024-08-15 | — | — | US | disclosed |
| CN-118164881-A | Thioamide compound and application thereof | 沈阳中化农药化工研发有限公司 | 2024-06-11 | — | — | CN | disclosed |
| EP-3661923-B1 | N-HETEROCYCLIC COMPOUNDS AS OREXIN 2 AGONISTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | TAKEDA PHARMACEUTICALS CO (JP) | 2024-05-15 | — | — | EP | disclosed |
| US-11952355-B2 | Method of preparing malononitrile oxime ether compound and intermediate compound | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2024-04-09 | — | — | US | disclosed |
| CN-114276291-B | Method for preparing malononitrile oxime ether compound and intermediate compound | 沈阳中化农药化工研发有限公司 | 2023-11-21 | — | — | CN | disclosed |
| EP-3395795-B1 | MALONONITRILE OXIME ETHER COMPOUND AND USE THEREOF | SHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD (CN) | 2023-07-19 | — | — | EP | disclosed |
| CN-113968799-B | Malononitrile compound and application thereof | 沈阳化工大学 | 2023-07-04 | — | — | CN | disclosed |
| US-4703044-A | Imidazoquinolines containing other heterocyclic groups, useful as anti-ulcer or anti-secretory agents | JOHN WYETH & BROTHER LIMITED (GB) | 1987-10-27 | — | — | US | disclosed |
| EP-0192060-A1 | Heterocyclic compounds | NIHON BAYER AGROCHEM K.K. (JP) | 1986-08-27 | — | — | EP | disclosed |
| EP-0146370-A2 | Imidazoquinolines containing other heterocyclic groups | JOHN WYETH & BROTHER LIMITED (GB) | 1985-06-26 | — | — | EP | disclosed |
| US-4336059-A | Herbicidal and plant-growth-regulating N-(heterocyclyl)-methylacetanilide | CHEVRON RESEARCH COMPANY (US) | 1982-06-22 | — | — | US | disclosed |
| US-4307105-A | FUNGICIDES AND BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1981-12-22 | — | — | US | disclosed |
| US-4221584-A | Herbicidal and plant-growth-regulating N-(heterocyclyl)-methylacetanilides | CHEVRON RESEARCH COMPANY (US) | 1980-09-09 | — | — | US | disclosed |
| US-4161571-A | GELATION INHIBITORS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-07-17 | — | — | US | disclosed |
| US-4080493-A | POLYBUTADIENE, POLYISOPRENE, GELATION INHIBITOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11952355-B2 | Method of preparing malononitrile oxime ether compound and intermediate compound | CYP2E1, CYP3A4, POR | GFER 717/4885RAB9A 3427/4885NPC1 4653/4885 |
| US-20240270737-A1 | SMALL MOLECULAR INHIBITORS OF STING SIGNALING COMPOSITIONS AND METHODS OF USE | STING1, IRF3, MAVS | GFER 4720/4885RAB9A 1949/4885NPC1 2662/4885 |
| US-12319684-B2 | Agonists of the apelin receptor and methods of use thereof | APLNR, AGTR1, AGTR2 | GFER 1608/4885RAB9A 2081/4885NPC1 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.